Published in Biochemistry on June 18, 2002
The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity. Proc Natl Acad Sci U S A (2003) 2.13
A novel phosphatase cascade regulates differentiation in Trypanosoma brucei via a glycosomal signaling pathway. Genes Dev (2010) 1.16
Physiological and toxic effects of purine intermediate 5-amino-4-imidazolecarboxamide ribonucleotide (AICAR) in yeast. J Biol Chem (2011) 0.90
NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol (1998) 21.48
Phosphorylation-dephosphorylation of enzymes. Annu Rev Biochem (1979) 11.34
Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell (1998) 6.48
IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex. Nature (1998) 6.15
Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proc Natl Acad Sci U S A (1999) 5.28
Engineering unnatural nucleotide specificity for Rous sarcoma virus tyrosine kinase to uniquely label its direct substrates. Proc Natl Acad Sci U S A (1997) 3.59
The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2. Proc Natl Acad Sci U S A (1997) 3.23
The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IkappaB kinase. Chem Biol (2001) 2.41
A new class of phosphotransferases phosphorylated on an aspartate residue in an amino-terminal DXDX(T/V) motif. J Biol Chem (1998) 2.29
Hydrolysis of phosphate monoesters: a biological problem with multiple chemical solutions. Trends Biochem Sci (1992) 2.00
Unnatural ligands for engineered proteins: new tools for chemical genetics. Annu Rev Biophys Biomol Struct (2000) 1.99
Catalysis by a multiprotein IkappaB kinase complex. Science (1997) 1.96
Mutational analysis of a Ser/Thr phosphatase. Identification of residues important in phosphoesterase substrate binding and catalysis. J Biol Chem (1994) 1.83
Identification of a novel phosphatase sequence motif. Protein Sci (1997) 1.78
Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide alpha',beta'-epoxyketones. Chem Biol (1999) 1.65
A superfamily of metalloenzymes unifies phosphopentomutase and cofactor-independent phosphoglycerate mutase with alkaline phosphatases and sulfatases. Protein Sci (1998) 1.54
Protein-tyrosine phosphatases. J Biol Chem (1994) 1.54
Total synthesis of the potent proteasome inhibitor epoxomicin: a useful tool for understanding proteasome biology. Bioorg Med Chem Lett (1999) 1.54
Evolution of a bifunctional enzyme: 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Proc Natl Acad Sci U S A (1989) 1.47
Eponemycin analogues: syntheses and use as probes of angiogenesis. Bioorg Med Chem (1998) 1.34
Eponemycin exerts its antitumor effect through the inhibition of proteasome function. Cancer Res (1999) 1.31
Mechanistic studies of phosphoserine phosphatase, an enzyme related to P-type ATPases. J Biol Chem (1999) 1.17
Rapid determination of inorganic phosphate in biological systems by a highly sensitive photometric method. Anal Biochem (1975) 1.17
A specific alkaline p-nitrophenylphosphatase activity from baker's yeast. Biochim Biophys Acta (1972) 1.16
Molecular basis for substrate specificity of protein kinases and phosphatases. Int J Biochem (1986) 1.16
Functional characterization of the low-molecular-mass phosphotyrosine-protein phosphatase of Acinetobacter johnsonii. J Mol Biol (1998) 1.14
Electrostatic evaluation of the signature motif (H/V)CX5R(S/T) in protein-tyrosine phosphatases. Biochemistry (1998) 1.08
Identification of the Mg2+-binding site in the P-type ATPase and phosphatase members of the HAD (haloacid dehalogenase) superfamily by structural similarity to the response regulator protein CheY. Biochem J (1999) 1.04
Molecular characterization of a specific p-nitrophenylphosphatase gene, PHO13, and its mapping by chromosome fragmentation in Saccharomyces cerevisiae. Mol Gen Genet (1989) 1.01
MDP-1: A novel eukaryotic magnesium-dependent phosphatase. Biochemistry (2000) 0.95
Specificity of protein phosphotyrosine phosphatases. Comparison with mammalian alkaline phosphatase using polypeptide substrates. J Biol Chem (1985) 0.95
Small-molecule inhibitors of the cell cycle. Curr Opin Chem Biol (2000) 0.92
A specific alkaline phosphatase from Saccharomyces cerevisiae with protein phosphatase activity. FEMS Microbiol Lett (1998) 0.91
Biochemical characterization of osteo-testicular protein tyrosine phosphatase and its functional significance in rat primary osteoblasts. Biochemistry (2001) 0.90
Characterisation of the specific p-nitrophenylphosphatase gene and protein of Schizosaccharomyces pombe. Eur J Biochem (1991) 0.84
Feverfew in rheumatoid arthritis: a double blind, placebo controlled study. Ann Rheum Dis (1989) 0.84
The efficacy and safety of feverfew (Tanacetum parthenium L.): an update of a systematic review. Public Health Nutr (2000) 0.83
Further characterization of a specific p-nitrophenylphosphatase from baker's yeast. Biochim Biophys Acta (1973) 0.81
Feverfew for preventing migraine. Cochrane Database Syst Rev (2000) 0.76
A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation. Nat Genet (2011) 3.18
Targeting bacterial virulence: inhibitors of type III secretion in Yersinia. Chem Biol (2003) 2.61
Molecular understanding and modern application of traditional medicines: triumphs and trials. Cell (2007) 2.51
A small-molecule inhibitor of type III secretion inhibits different stages of the infectious cycle of Chlamydia trachomatis. Proc Natl Acad Sci U S A (2006) 2.01
Small-molecule hydrophobic tagging-induced degradation of HaloTag fusion proteins. Nat Chem Biol (2011) 1.98
Chemical genetic control of protein levels: selective in vivo targeted degradation. J Am Chem Soc (2004) 1.93
A chemical and genetic approach to the mode of action of fumagillin. Chem Biol (2006) 1.91
Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease. Proc Natl Acad Sci U S A (2007) 1.75
Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle. FEBS Lett (2007) 1.50
Proteasome inhibition by fellutamide B induces nerve growth factor synthesis. Chem Biol (2008) 1.45
Salicylidene acylhydrazides that affect type III protein secretion in Salmonella enterica serovar typhimurium. Antimicrob Agents Chemother (2007) 1.43
Targeting the von Hippel-Lindau E3 ubiquitin ligase using small molecules to disrupt the VHL/HIF-1α interaction. J Am Chem Soc (2012) 1.34
Inhibition of type III secretion in Salmonella enterica serovar Typhimurium by small-molecule inhibitors. Antimicrob Agents Chemother (2007) 1.31
Development of Protacs to target cancer-promoting proteins for ubiquitination and degradation. Mol Cell Proteomics (2003) 1.27
Dissecting fragment-based lead discovery at the von Hippel-Lindau protein:hypoxia inducible factor 1α protein-protein interface. Chem Biol (2012) 1.26
Design and Applications of Bifunctional Small Molecules: Why Two Heads Are Better Than One. ACS Chem Biol (2008) 1.25
Dual mTORC1/mTORC2 inhibition diminishes Akt activation and induces Puma-dependent apoptosis in lymphoid malignancies. Blood (2011) 1.20
Reversal of the antichlamydial activity of putative type III secretion inhibitors by iron. Infect Immun (2007) 1.20
Small-molecule control of intracellular protein levels through modulation of the ubiquitin proteasome system. Angew Chem Int Ed Engl (2014) 1.18
A role for planar cell polarity signaling in angiogenesis. Angiogenesis (2008) 1.18
Triptolide reduces cystogenesis in a model of ADPKD. J Am Soc Nephrol (2008) 1.18
Identification of bacterial target proteins for the salicylidene acylhydrazide class of virulence-blocking compounds. J Biol Chem (2011) 1.15
Synthetic studies on amphidinolide B1. Org Lett (2006) 1.15
Identification of hydrophobic tags for the degradation of stabilized proteins. Chembiochem (2012) 1.11
Activation of the planar cell polarity formin DAAM1 leads to inhibition of endothelial cell proliferation, migration, and angiogenesis. Proc Natl Acad Sci U S A (2010) 1.10
Stereoselective assembly of a 1,3-diene via coupling between an allenic acetate and a (B)-alkylborane: synthetic studies on amphidinolide B1. Org Lett (2005) 1.09
Total synthesis and structure-activity investigation of the marine natural product neopeltolide. J Am Chem Soc (2009) 1.08
Chemical genetics: adding to the developmental biology toolbox. Dev Cell (2003) 1.08
Small-molecule inhibitors of the interaction between the E3 ligase VHL and HIF1α. Angew Chem Int Ed Engl (2012) 1.07
Chemical inducers of targeted protein degradation. J Biol Chem (2010) 1.07
Targeted gene disruption of methionine aminopeptidase 2 results in an embryonic gastrulation defect and endothelial cell growth arrest. Proc Natl Acad Sci U S A (2006) 1.07
Triptolide-induced transcriptional arrest is associated with changes in nuclear substructure. Cancer Res (2008) 1.06
CHK1 and WEE1 inhibition combine synergistically to enhance therapeutic efficacy in acute myeloid leukemia ex vivo. Haematologica (2013) 1.06
Targeted intracellular protein degradation induced by a small molecule: En route to chemical proteomics. Bioorg Med Chem Lett (2008) 1.05
Protection of mice from a Chlamydia trachomatis vaginal infection using a Salicylidene acylhydrazide, a potential microbicide. J Infect Dis (2011) 1.04
Inhibitors of type III secretion in Yersinia: design, synthesis and multivariate QSAR of 2-arylsulfonylamino-benzanilides. Bioorg Med Chem (2007) 1.04
Studies on calcium dependence reveal multiple modes of action for triptolide. Chem Biol (2005) 1.01
Gene expression profile of the regeneration epithelium during axolotl limb regeneration. Dev Dyn (2011) 1.01
Effects of selective checkpoint kinase 1 inhibition on cytarabine cytotoxicity in acute myelogenous leukemia cells in vitro. Clin Cancer Res (2012) 1.01
Statistical molecular design of a focused salicylidene acylhydrazide library and multivariate QSAR of inhibition of type III secretion in the Gram-negative bacterium Yersinia. Bioorg Med Chem (2010) 1.00
Multivalent sialic acid conjugates inhibit adenovirus type 37 from binding to and infecting human corneal epithelial cells. Antiviral Res (2006) 1.00
Highly efficient targeted mutagenesis in axolotl using Cas9 RNA-guided nuclease. Development (2014) 1.00
Candidate vaginal microbicides with activity against Chlamydia trachomatis and Neisseriagonorrhoeae. Int J Antimicrob Agents (2010) 0.99
Characterization of the effects of salicylidene acylhydrazide compounds on type III secretion in Escherichia coli O157:H7. Infect Immun (2009) 0.99
HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of HaloTag Fusion Proteins. ACS Chem Biol (2015) 0.99
Design, synthesis, and multivariate quantitative structure-activity relationship of salicylanilides--potent inhibitors of type III secretion in Yersinia. J Med Chem (2007) 0.98
Salicylanilides are potent inhibitors of type III secretion in Yersinia. Adv Exp Med Biol (2003) 0.98
From epoxomicin to carfilzomib: chemistry, biology, and medical outcomes. Nat Prod Rep (2013) 0.98
Triptolide directly inhibits dCTP pyrophosphatase. Chembiochem (2011) 0.95
Neurotrophic peptide aldehydes: solid phase synthesis of fellutamide B and a simplified analog. Bioorg Med Chem Lett (2006) 0.94
Pre-clinical pharmacokinetics and anti-chlamydial activity of salicylidene acylhydrazide inhibitors of bacterial type III secretion. J Antibiot (Tokyo) (2012) 0.93
A single amino acid residue defines the difference in ovalicin sensitivity between type I and II methionine aminopeptidases. J Biol Chem (2003) 0.93
Total synthesis and biological evaluation of tyroscherin. Org Lett (2010) 0.92
Removal of Acyl Protective Groups from Glycopeptides: Base Does Not Epimerize Peptide Stereocenters, and beta-Elimination Is Slow. J Org Chem (1996) 0.91
Chemical approaches to controlling intracellular protein degradation. Chembiochem (2005) 0.91
Posttranslational protein knockdown coupled to receptor tyrosine kinase activation with phosphoPROTACs. Proc Natl Acad Sci U S A (2013) 0.91
Mutations in hemG mediate resistance to salicylidene acylhydrazides, demonstrating a novel link between protoporphyrinogen oxidase (HemG) and Chlamydia trachomatis infectivity. J Bacteriol (2013) 0.89
Triptolide reduces cyst formation in a neonatal to adult transition Pkd1 model of ADPKD. Nephrol Dial Transplant (2010) 0.89
Expression, purification, crystallization and initial X-ray diffraction analysis of thiol peroxidase from Yersinia pseudotuberculosis. Acta Crystallogr Sect F Struct Biol Cryst Commun (2010) 0.89
Disruption of Wnt planar cell polarity signaling by aberrant accumulation of the MetAP-2 substrate Rab37. Chem Biol (2011) 0.89
Total synthesis of TMC-95A and -B via a new reaction leading to Z-enamides. Some preliminary findings as to SAR. J Am Chem Soc (2004) 0.88
Derivatives of 8-hydroxyquinoline--antibacterial agents that target intra- and extracellular Gram-negative pathogens. Bioorg Med Chem Lett (2012) 0.88
Multivalent HSA conjugates of 3'-sialyllactose are potent inhibitors of adenoviral cell attachment and infection. Chembiochem (2005) 0.88
Development and characterization of proteasome inhibitors. Methods Enzymol (2005) 0.87
Pseudoceramines A-D, new antibacterial bromotyrosine alkaloids from the marine sponge Pseudoceratina sp. Org Biomol Chem (2011) 0.87
Simplified synthetic TMC-95A/B analogues retain the potency of proteasome inhibitory activity. Chembiochem (2003) 0.86
Structural characterisation of Tpx from Yersinia pseudotuberculosis reveals insights into the binding of salicylidene acylhydrazide compounds. PLoS One (2012) 0.86
Gel-phase 19F NMR spectral quality for resins commonly used in solid-phase organic synthesis; a study of peptide solid-phase glycosylations. Org Biomol Chem (2004) 0.86
Chemical genetics: exploring the role of the proteasome in cell biology using natural products and other small molecule proteasome inhibitors. J Med Chem (2008) 0.85
Design, synthesis, and evaluation of N-acyl modified sialic acids as inhibitors of adenoviruses causing epidemic keratoconjunctivitis. J Med Chem (2009) 0.84
Design of a general-purpose European compound screening library for EU-OPENSCREEN. ChemMedChem (2014) 0.83
Formation of lactones from sialylated MUC1 glycopeptides. Org Biomol Chem (2006) 0.83
Synthesis of the C3-C18 fragment of amphidinolides G and H. Org Lett (2007) 0.83
PARP inhibitor with selectivity toward ADP-ribosyltransferase ARTD3/PARP3. ACS Chem Biol (2013) 0.83
A potent trivalent sialic acid inhibitor of adenovirus type 37 infection of human corneal cells. Angew Chem Int Ed Engl (2011) 0.82
Microarray analysis of microRNA expression during axolotl limb regeneration. PLoS One (2012) 0.82
Targeting cyst initiation in ADPKD. J Am Soc Nephrol (2008) 0.82
2-[4,5-Difluoro-2-(2-fluorobenzoylamino)-benzoylamino]benzoic acid, an antiviral compound with activity against acyclovir-resistant isolates of herpes simplex virus types 1 and 2. Antimicrob Agents Chemother (2012) 0.81
Developing microcolin A analogs as biological probes. Bioorg Med Chem Lett (2005) 0.81
Discovery of ligands for ADP-ribosyltransferases via docking-based virtual screening. J Med Chem (2012) 0.81
Chemical biology: Greasy tags for protein removal. Nature (2012) 0.81
Poly(ADP-ribose) polymerase inhibitors sensitize cancer cells to death receptor-mediated apoptosis by enhancing death receptor expression. J Biol Chem (2014) 0.80
In vitro anti-HIV-1 activity of salicylidene acylhydrazide compounds. Int J Antimicrob Agents (2012) 0.80
Chemical genetics: a small molecule approach to neurobiology. Neuron (2002) 0.80
Small-molecule screening using a whole-cell viral replication reporter gene assay identifies 2-{[2-(benzoylamino)benzoyl]amino}-benzoic acid as a novel antiadenoviral compound. Antimicrob Agents Chemother (2010) 0.80
Synthesis, biological evaluation, and structure-activity relationships of 2-[2-(benzoylamino)benzoylamino]benzoic acid analogues as inhibitors of adenovirus replication. J Med Chem (2012) 0.80
Reversal of TNP-470-induced endothelial cell growth arrest by guanine and guanine nucleosides. J Pharmacol Exp Ther (2010) 0.79
The resveratrol tetramer (-)-hopeaphenol inhibits type III secretion in the gram-negative pathogens Yersinia pseudotuberculosis and Pseudomonas aeruginosa. PLoS One (2013) 0.79
Identification and characterization of a peptidic ligand for Ras. Chembiochem (2010) 0.79
Solving the supply of resveratrol tetramers from Papua New Guinean rainforest anisoptera species that inhibit bacterial type III secretion systems. J Nat Prod (2014) 0.78
Syntheses of pseudoceramines A-D and a new synthesis of spermatinamine, bromotyrosine natural products from marine sponges. Org Biomol Chem (2011) 0.78
Loading of the antigen-presenting protein CD1d with synthetic glycolipids. Chembiochem (2004) 0.78
A HaloTag-based small molecule microarray screening methodology with increased sensitivity and multiplex capabilities. ACS Chem Biol (2012) 0.78
Myriaporone 3/4 structure--activity relationship studies define a pharmacophore targeting eukaryotic protein synthesis. Mol Biosyst (2006) 0.78
N-acylated derivatives of sulfamethoxazole and sulfafurazole inhibit intracellular growth of Chlamydia trachomatis. Antimicrob Agents Chemother (2014) 0.78
Generating and identifying axolotls with targeted mutations using Cas9 RNA-guided nuclease. Methods Mol Biol (2015) 0.78
Natural product inhibitors of the ubiquitin-proteasome pathway. Curr Drug Targets (2011) 0.77
HIV protease-mediated activation of sterically capped proteasome inhibitors and substrates. J Am Chem Soc (2011) 0.77